SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment
SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment is a paper indexed in ScholarIQ from OpenAlex.
How many citations does SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment have?
SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment has 5 citations in the OpenAlex counts ScholarIQ stores.
When was SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment published?
SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment has 2024 year in the ScholarIQ index.
What is the open-access status of SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment?
SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment has hybrid oa status in the ScholarIQ index.
What is the DOI of SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment?
The DOI for SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment is on the source record.
What is the PMID of SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment?
The PMID for SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment is on the source record.
What is the OpenAlex record for SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment?
The OpenAlex for SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment is on the source record.